معرفی
Joseph Lim, MD is a Professor of Medicine at Yale University School of Medicine, specializing in Hepatology and Gastroenterology. He serves as Director of Clinical Hepatology, Vice-Chief of Hepatology in the Digestive Diseases Section, and Director of the Yale Viral Hepatitis Program. His clinical and research focus includes chronic hepatitis B/C infections, fatty liver disease, liver cirrhosis, and hepatocellular carcinoma. Lim completed his MD at Northwestern University, residency at Yale New Haven Hospital, and fellowship at Stanford University.
Education:
- MD, Northwestern University Medical School (1999)
- Residency in Internal Medicine, Yale-New Haven Hospital (2002)
- Fellowship in Gastroenterology & Hepatology, Stanford University Medical Center (2005)
Research Interests: Lim's work centers on improving outcomes for chronic liver disease patients. He leads national/international cohort studies on hepatitis therapies and VA liver disease outcomes in HIV-coinfected patients. Key areas include hepatitis delta virus epidemiology, hepatotoxic medication risk assessment, and liver cancer prediction models.
Articles Trends: Recent publications emphasize hepatitis virus management, liver injury from medications, and machine learning applications in liver disease diagnosis. His 2024 Hepatotoxicity Score method has advanced drug safety assessment in chronic liver patients.
Awards: Howard M. Spiro Faculty Teaching Award (2009) from Yale SOM highlights his educational contributions.
Grants & Trials: Principal Investigator for clinical trials NATiV3 (NASH treatment) and MIRNA (NASH resolution). Active in translational research bridging clinical practice and drug discovery.
Labs/Teams: Leads Yale Viral Hepatitis Program and collaborates with teams like the Center for Interdisciplinary Research on AIDS. His lab focuses on viral hepatitis pathogenesis and innovative diagnostic tools.
